Nasal dermoplasty for Japanese hereditary hemorrhagic telangiectasia

Auris Nasus Larynx

Volumn 33, Issue 4, 2006, Pages 423-428

  Ichimura, Keiichi ^a   Tanaka, Hidetaka ^a   Yamamoto, Yoshinori ^a   Nakamura, Ken ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Epistaxis; Hereditary hemorrhagic telangiectasis; Nasal dermoplasty

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPISTAXIS; FEMALE; HUMAN; JAPAN; MALE; MEDICAL RECORD REVIEW; NOSE DERMOPLASTY; NOSE OBSTRUCTION; NOSE SURGERY; PATIENT SATISFACTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RENDU OSLER WEBER DISEASE; RISK REDUCTION; SKIN GRAFT; SURGICAL PATIENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALGINATES; ELECTROCOAGULATION; EPISTAXIS; FEMALE; GLUCURONIC ACID; HEMOSTATICS; HEXURONIC ACIDS; HUMANS; JAPAN; MALE; MIDDLE AGED; NASAL CAVITY; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; SKIN TRANSPLANTATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33749238707     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2006.03.001     Document Type: Article

References (25)

1. Saunders W.H. Septal dermoplasty: ten years experience. Trans Am Acad Ophthalmol Otolaryngol 72 (1968) 153-160
2. Ichimura K., Nakamura N., Tanaka T., and Oka Y. Nasal dermoplasty for Osler's disease. Practica Otolaryngol Kyoto 87 (1994) 895-900 (in Japanese)
3. Fiorella M.L., Ross D., Henderson K.J., and White Jr. R.I. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115 (2005) 301-305
4. Begbie M.E., Wallace G.M.F., and Sholvlin C.L. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 79 (2003) 18-24
5. Urness L.D., Sorensen L.K., and Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26 (2000) 328-331
6. Pau H., Carney A.S., and Marty G.E. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol 26 (2001) 93-98
7. Braverman I.M., Keh A., and Jacobson B.S. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95 (1990) 442-447
8. Jahnke V. Ultrastructure of hereditary telangiectasia. Arch Otolaryngol 91 (1970) 262-265
9. Menefee M.G., Flessa H.C., Glueck H.I., and Hogg S.P. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): an electron microscopic study of the vascular lesions before and after therapy with hormones. Arch Otolaryngol 101 (1975) 246-251
10. Folz B.J., Wollstein A.C., Lippert B.M., and Werner J.A. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Am J Rhinol 19 (2005) 65-70
11. Plauchu H., de Chadarevian J.P., Bideau A., and Robert J.M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32 (1989) 291-297
12. Kjeldsen A.D., Vase P., and Green A. Hereditary hemorrhagic telangiectasia (HHT): a population-based study of prevalence and mortality in Danish HHT patients. J Intern Med 245 (1999) 31-39
13. Dakeishi M., Shioya T., Wada Y., Shindo T., Otaka K., Manabe M., et al. Genetic epidemiology of hereditary haemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19 (2002) 140-148
14. Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J., et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (2000) 66-67
15. White R.I., and Pollak J.S. Pulmonary arteriovenous malformations: options for management. Ann Thorac Surg 57 (1994) 519-521
16. Shah R.K., Dhingra J.K., and Shapshay S.M. Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112 (2002) 767-773
17. Jameson J.J., and Cave D.R. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114 (2004) 705-709
18. Saunders W.H. Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations. Trans Am Acad Ophthalmol Otolaryngol 64 (1960) 500-506
19. McCabe W.P., and Kelly Jr. A.P. Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectasia within a nasal skin graft. Plast Reconstr Surg 50 (1972) 114-118
20. Uls C., Vase P., and Stoksted P. Long-term results of dermoplasty in the treatment of hereditary haemorrhagic telangiectasia. J Laryngol Otol 97 (1983) 223-226
21. McCaffery T.B., Kern E.B., and Lake C.E. Management of epistaxis in hereditary hemorrhagic telangiectasia: review of 80 cases. Arch Otolaryngol 103 (1977) 627-630
22. Siegel M.B., Keane W.M., Atkins J.P., and Rosen M.R. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 105 (1991) 675-679
23. Lund V.J., and Howard D.J. Closure of the nasal cavities in the treatment of refractory hereditary hemorrhagic telangiectasia. J Laryngol Otol 111 (1997) 30-33
24. Gluckman J.L., and Portugal L.G. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104 (1994) 1174-1177
25. Hitchings A.E., Lennox P.A., Lund V.J., and Howard D.J. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19 (2005) 75-78